Inflammatory marker but not adipokine predicts mortality among long-term hemodialysis patients

Mediators of Inflammation

Volumn 2007, Issue , 2007, Pages

  Tsai, Yu Che ^a   Lee, Chien Te ^a   Huang, Tiao Lai ^a   Cheng, Ben Chung ^a   Kuo, Chien Chun ^b   Su, Yih ^b   Ng, Hwee Yeong ^a   Yang, Chih Chau ^a   Chuang, Fong Rong ^a   Liao, Shang Chih ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHENG SHIU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INFLAMMATORY MARKER; LEPTIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CLINICAL FEATURE; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INFECTION; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SURVIVOR; AGED; BLOOD; HYPOALBUMINEMIA; INFLAMMATION; KIDNEY DISEASE; METABOLISM; METHODOLOGY; MIDDLE AGED; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY; TIME; TREATMENT OUTCOME;

ADIPOKINES; ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPOALBUMINEMIA; INFLAMMATION; KIDNEY DISEASES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 38749083417     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2007/19891     Document Type: Article

References (24)

1. R. N. Foley rn_foley@hotmall.com P. S. Parfrey M. J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease. American Journal of Kidney Diseases 32 5, suppl. 3 1998 112 119
2. P. Stenvinkel O. Heimbürger B. Lindholm G. A. Kaysen J. Bergström Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrology Dialysis Transplantation 15 7 2000 953 960
3. K. Kalantar-Zadeh kamkal@ucla.edu T. A. Ikizler G. Block M. M. Avram J. D. Kopple Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. American Journal of Kidney Diseases 42 5 2003 864 881
4. P. Stenvinke peter.stenvinkel@klinvet.ki.se P. Barany S. H. Chung B. Lindholm O. Heimbürger A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients. Nephrology Dialysis Transplantation 17 7 2002 1266 1274
5. C. Zoccali carmine.zoccali@tin.it F. Mallamaci G. Tripepi Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease. Nephrology Dialysis Transplantation 19, suppl. 5 2004 67 72
6. J. Y. Yeun R. A. Levine V. Mantadilok G. A. Kaysen C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. American Journal of Kidney Diseases 35 3 2000 469 476
7. K. Iseki M. Tozawa S. Yoshi K. Fukiyama Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrology Dialysis Transplantation 14 8 1999 1956 1960
8. J. Axelsson O. Heimbürger B. Lindholm P. Stenvinkel peter.stenvinkel@klinvet.ki.se Adipose tissue and its relation to inflammation: the role of adipokines. Journal of Renal Nutrition 15 1 2005 131 136
9. J. Zimmermann j.zimmermann@medizin.uni-wuerzburg.de S. Herrlinger A. Pruy T. Metzger C. Wanner Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney International 55 2 1999 648 658
10. D. A. Goodkin J. Bragg-Gresham K. G. Koenig Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology 14 12 2003 3270 3277
11. C. Wanner T. Metzger C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrology Dialysis Transplantation 17, suppl. 8 2002 29 32
12. P. Stenvinkel peter.stenvinkel@klinvet.ki.se A. Alvestrand Inflammation in end-stage renal disease: sources, consequences, and therapy. Seminars in Dialysis 15 5 2002 329 337
13. R. Pecoits-Filho roberto.pecoits-filho@klinvet.ki.se P. Barany B. Lindholm O. Heimbürger P. Stenvinkel Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrology Dialysis Transplantation 17 9 2002 1684 1688
14. J. Bergstrom B. Lindholm Malnutrition, cardiac disease, and mortality: an integrated point of view. American Journal of Kidney Diseases 32 5 1998 834 841
15. P. Stenvinkel peter.stenvinkel@klinvet.ki.se O. Heimbürger F. Paultre Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney International 55 5 1999 1899 1911
16. B. R. Bistrian bbistria@caregroup.bidme.harvard.edu Interaction between nutrition and inflammation in end-stage renal disease. Blood Purification 18 4 2000 333 336
17. C. Zoccali carmine.zoccali@tin.it G. Tripepi F. Cambareri Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients. Journal of Renal Nutrition 15 1 2005 125 130
18. C. Zoccali F. Mallamaci G. Tripepi Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. Journal of the American Society of Nephrology 13 1 2002 134 141
19. C. Zoccali Carmine.zoccali@tin.it F. Mallamaci G. Tripepi Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney International, Supplement 63 84 2003 65 68
20. C.-T. Lee ctlee33@adm.cgmh.org.tw C.-H. Lee Y. Su The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients. International Journal of Artificial Organs 27 10 2004 835 841
21. V. Menon vmenon@tufts-nemc.org L. Li X. Wang Adiponectin and mortality in patients with chronic kidney disease. Journal of the American Society of Nephrology 17 9 2006 2599 2606
22. S. Pilz H. Mangge B. Wellnitz Adiponectin and mortality in patients undergoing coronary angiography. Journal of Clinical Endocrinology and Metabolism 91 11 2006 4277 4286
23. R. S. Lindsay H. E. Resnick J. Zhu Adiponectin and coronary heart disease: the strong heart study. Arteriosclerosis, thrombosis, and vascular biology 25 3 2005 e15 e16
24. D. Rothenbacher H. Brenner W. März W. Koenig wolfgang. koenig@medizin.uni-ulm.de Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. European Heart Journal 26 16 2005 1640 1646